Comprehensive approach to the choice of therapy in patients with osteoarthritis at the first visit to the doctor. Expert consensus (literature review and resolution)

Osteoarthritis (OA) is the most common pathology of the musculoskeletal system and is a serious medical and social problem. OA is of particular importance in elderly and senile people due to the high frequency of comorbid pathology. Pain relief is a priority in the formation of individual therapeutic programs for patients with OA, starting from their first request for medical assistance. At the same time, due to the ambiguity of existing clinical recommendations, most experts note a number of difficulties in prescribing treatment for patients with OA.

The article presents a consensus position of experts regarding a complex approach to the choice of therapy in patients with OA at the initial visit to the doctor. The article discusses: current clinical guidelines for the management of patients with OA; most common problems in the management of patients with OA in real clinical practice; goals of treatment strategies for OA taking into account the risk factors for its progression; an algorithm of pain relief during initial treatment in patients with OA; prevention of OA exacerbations with the use of basic structure-modifying drugs; recommendations for the choice of non-steroidal anti-inflammatory drugs.

According to experts, a rational approach to the treatment of OA is based on the combined use of non-drug and pharmacological methods with constant monitoring of therapy regimens and side effects. These recommendations can be considered disease-modifying strategies that in many cases allow improving functional status and achieving long-term remission in patients with OA.

1. Alekseeva LI, Taskina EA, Kashevarova NG. Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(2):9-21. (In Russ.). doi: 10.14412/1996-7012-2019-2-9-21

2. Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet. 2020 Nov 28;396(10264): 1711-12. doi: 10.1016/S0140-6736(20)32230-3. Epub 2020 Nov 4.

3. Meessen JMTA, Leichtenberg CS, Tilbury C, et al. Frailty in end-stage hip or knee osteoarthritis: validation of the Groningen Frailty Indicator (GFI) questionnaire. Rheumatol Int. 2018 May;38(5):917-24. doi: 10.1007/s00296-017-3868-1. Epub 2017 Nov 17.

4. Macfarlane GJ, Barnish MS, Jones GT. Persons with chronic widespread pain experience excess mortality: longitudinal results from UK Biobank and meta-analysis. Ann Rheum Dis. 2017 Nov;76(11):1815-22. doi: 10.1136/annrheumdis-2017-211476. Epub 2017 Jul 21.

5. de Rooij M, van der Leeden M, Heymans MW, et al. Prognosis of Pain and Physical Functioning in Patients With Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken). 2016 Apr;68(4):481-92. doi: 10.1002/acr.22693.

6. Kashevarova NG, Zaitseva EM, Smirnov AV, Alekseeva LI. Pain as one of the risk factors for the progression of osteoarthritis of the knee joints. Nauchno-prakticheskaya revmatologiya. 2013;51(4):387-90. (In Russ.).

7. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec; 49(3):337-50. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30.

8. Kolasinski SL, Neogi T, Hochberg MC et al. 2019 American College of Rheumatology/ Arthritis Foundation Guideline for the Manage-ment of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-62. doi: 10.1002/acr.24131. Epub 2020 Jan 6.

9. Kloppenburg M, Kroon FB, Blanco FJ, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019 Jan;78(1): 16-24. doi: 10.1136/annrheumdis-2018-213826. Epub 2018 Aug 28.

10. Clinical recommendations «Chronic pain in elderly and senile patients». https://legalacts.ru/doc/klinicheskierekomendatsii-khronicheskaja-bol-u-patsientov-pozhilogo-i-starcheskogo/

11. Clinical recommendations «Osteoarthritis», All-Russian public organization «Association of Rheumatologists of Russia», 2016. https://pharmspb.ru/docs/lit/Revmatologia_Rekomendazii%20po%20diagnostike%20i%20lecheniyu%20osteoartroza%20(MZ%20RF,%202016).pdf

12. Alekseeva LI, Naumov AV. Management of osteoarthritis with comorbidity in general medical practice (clinical recommendations). Doktor.Ru. 2017;(5):51-69. (In Russ.).

13. Bastick AN, Runhaar J, Belo JN, et al. Prognostic factors for progression of clinical osteoarthritis of the knee: a systematic review of observational studies. Arthritis Res Ther. 2015 Jun 8;17(1):152. doi: 10.1186/s13075-015-0670-x.

14. Leyland KM, Gates LS, Sanchez- Santos MT, et al. Knee osteoarthritis and time-to all-cause mortality in six communitybased cohorts: an international meta-analysis of individual participant-level data. Aging Clin Exp Res. 2021 Mar;33(3):529-45. doi: 10.1007/s40520-020-01762-2. Epub 2021 Feb 15.

15. Putilina MV. Comorbidity in elderly patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;116(5):106-11. (In Russ.).

16. Yakhno NN, Kukushkin ML, Churyukanov MV, et al. New Definition of Pain by the International Association for the Study of Pain. Rossiiskii zhurnal boli. 2020;18(4):5-7. (In Russ.).

17. Bakhtadze MA, Churyukanov MV, Kukushkin ML, et al. Questionnaire for assessing central sensitization: linguistic adaptation of the Russian version. Russian Journal of Pain. Rossiiskii zhurnal boli. 2020;18(4):40-5. (In Russ.).

18. Tkacheva ON, editor. Metodicheskie rekomendatsii. V pomoshch' pozhilomu cheloveku i ego blizkim: fizicheskaya aktivnost' v pozhilom vozraste [Methodological recommendations. To help the elderly and their loved ones: physical activity in old age]. Moscow: Prometei; 2019. 62 p.

19. Beaudart C, Lengele L, Leclercq V, et al. Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time Horizon. Drugs. 2020 Dec;80(18):1947-59. doi: 10.1007/s40265-020-01423-8.

20. Yang W, Sun C, He SQ, et al. The Efficacy and Safety of Disease- Modifying Osteoarthritis Drugs for Knee and Hip Osteoarthritis – a Systematic Review and Network Meta-Analysis. J Gen Intern Med. 2021 Apr 12. doi: 10.1007/s11606-021-06755-z. Online ahead of print.

21. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec; 49(3):337-50. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30.

22. Karateev AE, Nasonov EL, Ivashkin VT, et al. Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines. Nauchno-prakticheskaya revmatologiya. 2018;56(S1):1-29. (In Russ.).

23. Pruss TP, Stroissnig H, Radnofer-Welte S, et al. Overview of the pharmacological properties, pharma – cokinetics and animal safety assessment of lornoxicam. Postgrad Med J. 1990;66 Suppl 4:S18-21.

24. Rose P, Steinhauser C. Comparison of Lornoxicam and Rofecoxib in Patients with Activated Osteoarthritis (COLOR Study). Clin Drug Investig. 2004;24(4):227-36. doi: 10.2165/00044011-200424040-00004.

25. Parada L, Marstein JP, Danilov A. Tolerability of the COX-1/COX-2 inhibitor lornoxicam in the treatment of acute and rheumatic pain. Pain Manag. 2016 Oct;6(5): 445-54. doi: 10.2217/pmt.16.7. Epub 2016 Apr 18.